Literature DB >> 28088670

Fibrin hydrogels induce mixed dorsal/ventral spinal neuron identities during differentiation of human induced pluripotent stem cells.

John M Edgar1, Meghan Robinson1, Stephanie M Willerth2.   

Abstract

We hypothesized that generating spinal motor neurons (sMNs) from human induced pluripotent stem cell (hiPSC)-derived neural aggregates (NAs) using a chemically-defined differentiation protocol would be more effective inside of 3D fibrin hydrogels compared to 2D poly-L-ornithine(PLO)/laminin-coated tissue culture plastic surfaces. We performed targeted RNA-Seq using next generation sequencing to determine the substrate-specific differences in gene expression that regulate cell phenotype. Cells cultured on both substrates expressed sMN genes CHAT and MNX1, though persistent WNT signaling contributed to a higher expression of genes associated with interneurons in NAs cultured in 3D fibrin scaffolds. Cells in fibrin also expressed lower levels of astrocyte progenitor genes and higher levels of the neuronal-specific gene TUBB3, suggesting a purer population of neurons compared to 2D cultures. STATEMENT OF SIGNIFICANCE: Fibrin scaffolds can support the neuronal differentiation of pluripotent stem cells. This study provides insight into how fibrin hydrogels affect neuronal induction by analyzing of the signaling pathways activated during the differentiation process. These insights can then be used to tailor the properties of these hydrogels to optimize the generation of sMNs for regenerative medicine applications. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibrin; Gene expression; Laminin; Motor neuron; Neural progenitor; RNA-Seq; Stem cells

Mesh:

Substances:

Year:  2017        PMID: 28088670     DOI: 10.1016/j.actbio.2017.01.040

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  6 in total

Review 1.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

Review 2.  Gene-Modified Stem Cells for Spinal Cord Injury: a Promising Better Alternative Therapy.

Authors:  Yirui Feng; Yu Li; Ping-Ping Shen; Bin Wang
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 5.739

Review 3.  Development and Application of Three-Dimensional Bioprinting Scaffold in the Repair of Spinal Cord Injury.

Authors:  Dezhi Lu; Yang Yang; Pingping Zhang; Zhenjiang Ma; Wentao Li; Yan Song; Haiyang Feng; Wenqiang Yu; Fuchao Ren; Tao Li; Hong Zeng; Jinwu Wang
Journal:  Tissue Eng Regen Med       Date:  2022-06-29       Impact factor: 4.169

Review 4.  Effectiveness of Bioinks and the Clinical Value of 3D Bioprinted Glioblastoma Models: A Systematic Review.

Authors:  Shye Wei Leong; Shing Cheng Tan; Mohd Noor Norhayati; Mastura Monif; Si-Yuen Lee
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

Review 5.  3-D Bioprinting of Neural Tissue for Applications in Cell Therapy and Drug Screening.

Authors:  Michaela Thomas; Stephanie M Willerth
Journal:  Front Bioeng Biotechnol       Date:  2017-11-17

6.  Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions.

Authors:  Jarel K Gandhi; Travis Knudsen; Matthew Hill; Bhaskar Roy; Lori Bachman; Cynthia Pfannkoch-Andrews; Karina N Schmidt; Muriel M Metko; Michael J Ackerman; Zachary Resch; Jose S Pulido; Alan D Marmorstein
Journal:  Stem Cells Transl Med       Date:  2019-02-15       Impact factor: 6.940

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.